An Orally Available Clinical Candidate to Treat Covid-19

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2022; 18(02): 0201
DOI: 10.1055/s-0041-1737252

Chemistry in Medicine and Biology

Contributor(s):

Dirk Trauner

,

Tufan K. Mukhopadhyay

M^pro inhibition - azabicyclo[3.1.0]hexane - Burgess reagent - thioimidate adduct

Article published online:
18 January 2022

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany